Cargando…
RVG29-modified microRNA-loaded nanoparticles improve ischemic brain injury by nasal delivery
Effective nose-to-brain delivery needs to be developed to treat neurodegenerative diseases. Regulating miR-124 can effectively improve the symptoms of ischemic brain injury and provide a certain protective effect from brain damage after cerebral ischemia. We used rat models of middle cerebral artery...
Autores principales: | Hao, Rubin, Sun, Bixi, Yang, Lihua, Ma, Chun, Li, Shuling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269067/ https://www.ncbi.nlm.nih.gov/pubmed/32400219 http://dx.doi.org/10.1080/10717544.2020.1760960 |
Ejemplares similares
-
Targeted brain delivery of RVG29‐modified rifampicin‐loaded nanoparticles for Alzheimer's disease treatment and diagnosis
por: Zhou, Ruiyi, et al.
Publicado: (2022) -
Targeting Small Molecule Delivery to the Brain and Spinal Cord via Intranasal Administration of Rabies Virus Glycoprotein (RVG29)-Modified PLGA Nanoparticles
por: Chung, Eugene P., et al.
Publicado: (2020) -
Preparation of baicalin-loaded ligand-modified nanoparticles for nose-to-brain delivery for neuroprotection in cerebral ischemia
por: Li, Xinxin, et al.
Publicado: (2022) -
Efficient Anti-Glioma Therapy Through the Brain-Targeted RVG15-Modified Liposomes Loading Paclitaxel-Cholesterol Complex
por: Xin, Xin, et al.
Publicado: (2021) -
Modified Stability of microRNA-Loaded Nanoparticles
por: Fresacher-Scheiber, Katja, et al.
Publicado: (2022)